Showing results (1261-1270 of 1,328) with videos related to

Sort By:
Pageof 133
Preventive Medicine Reports|November 29, 2023
Addressing cervical cancer disparities in Texas: Expansion of a community-based prevention initiative for medically underserved populationsSamantha H Batman, Melissa L Varon, Maria Daheri, et al.
The Journal of Infectious Diseases|September 10, 2020
SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma DonorsSarah E Benner, Eshan U Patel, Oliver Laeyendecker, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 19, 2005
Role of transcription factor KLF11 and its diabetes-associated gene variants in pancreatic beta cell functionBernadette Neve, Martin E Fernandez-Zapico, Vered Ashkenazi-Katalan, et al.
Neurology|July 21, 2006
GAMT deficiency: features, treatment, and outcome in an inborn error of creatine synthesisS Mercimek-Mahmutoglu, S Stoeckler-Ipsiroglu, A Adami, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2023
Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMMLChristopher T Letson, Maria E Balasis, Hannah Newman, et al.
The Journal of Biological Chemistry|June 7, 2013
Activation of the transcription factor GLI1 by WNT signaling underlies the role of SULFATASE 2 as a regulator of tissue regenerationIkuo Nakamura, Maite G Fernandez-Barrena, Maria C Ortiz-Ruiz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 25, 2018
<i>CDKN2A</i> Germline Rare Coding Variants and Risk of Pancreatic Cancer in Minority PopulationsRobert R McWilliams, Eric D Wieben, Kari G Chaffee, et al.
Journal of Clinical Microbiology|November 19, 2020
Evaluation of Serological SARS-CoV-2 Lateral Flow Assays for Rapid Point-of-Care TestingSteven E Conklin, Kathryn Martin, Yukari C Manabe, et al.
JCI Insight|June 10, 2025
Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancerLuis F Flores, David L Marks, Renzo E Vera, et al.
Pageof 133